KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Receivables - Other: 2010-2018

Historic Receivables - Other for Arbutus Biopharma (ABUS) over the last 7 years, with Mar 2018 value amounting to $128,000.

  • Arbutus Biopharma's Receivables - Other changed negligibly% to $128,000 in Q1 2018 from the same period last year, while for Mar 2018 it was $128,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $128,000 for FY2017, which is negligibly% changed negligibly from last year.
  • Arbutus Biopharma's Receivables - Other amounted to $128,000 in Q1 2018, which was down 0.00% from $128,000 recorded in Q4 2017.
  • Arbutus Biopharma's 5-year Receivables - Other high stood at $1.6 million for Q1 2015, and its period low was $128,000 during Q4 2015.
  • For the 3-year period, Arbutus Biopharma's Receivables - Other averaged around $128,000, with its median value being $128,000 (2018).
  • Its Receivables - Other has fluctuated over the past 5 years, first slumped by 93.65% in 2014, then surged by 287.14% in 2015.
  • Arbutus Biopharma's Receivables - Other (Quarterly) stood at $538,000 in 2014, then slumped by 76.21% to $128,000 in 2015, then remained steady at $128,000 in 2016, then remained steady at $128,000 in 2017, then remained steady at $128,000 in 2018.
  • Its Receivables - Other was $128,000 in Q1 2018, compared to $128,000 in Q4 2017 and $128,000 in Q3 2017.